v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2026, and 2025, and their accounts receivable balance as of March 31, 2026:

 

  

Sales % Three

Months Ended

March 31, 2026

  

Sales % Three

Months Ended

March 31, 2025

  

Accounts

receivable

balance March

31, 2026

 
Customer A   96%   44%  $18,715 
Customer B   -%   28%  $- 
Customer C   -%   20%  $- 
SCHEDULE OF DISAGGREGATION OF REVENUE

The following table disaggregates our revenue by major source for the three months ended March 31, 2026, and 2025:

 

   2026   2025 
   Three months ended March 31, 
   2026   2025 
Sourced and distributed products  $315   $3,024 
OED Installations   55,738    39,233 
Total  $56,053   $42,257 
SCHEDULE OF DERIVATIVE INSTRUMENTS

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2026, and December 31, 2025, for each fair value hierarchy level:

 

March 31, 2026  Derivative
Liabilities		   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $2,955,700   $2,955,700 

 

December 31, 2025  Derivative
Liabilities		   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $4,193,434   $4,193,434 
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

   March 31,
2026		   March 31,
2025		 
Convertible preferred stock (1)   5,679,090    

2,465,953

 
Unexercised common stock purchase warrants (1)   1,271,405    

146,405

 
Convertible notes payable (1)   76,482,377    94,286 
Promissory notes payable (1)   8,064,071    1,515,493 
 Total   91,496,943    4,222,137 

 

(1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position.